Toxoplasma chorioretinitis
ICD-10 B57.0 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. Toxoplasmosis is often acquired through ingestion of oocysts found in contaminated food or water, or through contact with infected cat feces. In immunocompetent individuals, the infection may be asymptomatic or present with mild flu-like symptoms. However, in those with weakened immune systems, such as patients with HIV/AIDS or those undergoing immunosuppressive therapy, the risk of developing chorioretinitis increases significantly. Diagnosis is typically made through clinical examination, supported by imaging studies such as fundus photography or optical coherence tomography, and serological tests for Toxoplasma antibodies. Treatment usually involves the use of pyrimethamine and sulfadiazine, along with leucovorin to mitigate the side effects of pyrimethamine. Early diagnosis and treatment are crucial to prevent irreversible damage to the retina and preserve vision.
Detailed ocular examination findings, imaging results, and treatment plans.
Patients presenting with vision changes, floaters, or eye pain.
Ensure documentation reflects the extent of retinal involvement and any associated systemic symptoms.
Comprehensive patient history, including risk factors for Toxoplasma infection and serological test results.
Immunocompromised patients with new-onset ocular symptoms.
Document any co-infections or complications that may affect treatment.
Used when a new patient presents with symptoms suggestive of chorioretinitis.
Document the patient's history, symptoms, and findings from the examination.
Ophthalmologists should ensure comprehensive documentation of ocular health.
Common symptoms include blurred vision, floaters, eye pain, and in severe cases, vision loss. Patients may also experience systemic symptoms if they are immunocompromised.
